CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Steve Jurvetson

Co-founder, Future Ventures, Futures Ventures

Search every verified Steve Jurvetson interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Steve Jurvetson, co-founder of Future Ventures, participated in the BALLS high-power rocketry event organized by the Tripoli Rocketry Association in the Black Rock Desert, Nevada, in September 2024. During the event, he discussed his long-standing involvement in amateur rocketry, noting that he has been launching rockets for 20 years and that his son has been part of that activity since age three. He described the hobby as a way to inspire interest in rocket science, physics, and math, and mentioned that his son demands increasingly ambitious projects each year. Jurvetson also spoke about the technical aspects of the launches, including experiments involving duct tape and zip ties, and estimated one rocket could reach Mach 2.7. The event featured a home-built rocket flown by Thomas Brusca that reached approximately Mach 4.96. Jurvetson, who was an early investor in SpaceX, was shown preparing a rocket he considered unlikely to succeed, with a chance of success estimated at less than 10 percent.

Recent appearances

Notable quotes

“Data center capex is now over 1% of US GDP and one group (McKenzie) believes it's going to go to $6.7 trillion by 2030; what it's being choked by is electricity — it's not a generation problem, it's a transmission and local use problem.”

“This is why democracies and deregulated environments tend to achieve more changes because you have less regulatory capture, less of the big getting bigger, less authoritarian kind of regime protection and more disruption.”

“It takes quite a bit of money to get a drug through clinical trials — by some estimates a billion dollars with a 10% success rate — which is why for-profits raise hundreds of millions and why venture capital entered this sector.”

“The business case is it's a huge market and a huge unmet need; SSRIs are not effective in the vast majority of cases and drug companies like the idea that you'll be on an SSRI for the rest of your life.”

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →